Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates
Journal of Medicinal Chemistry · 2026
DOI: 10.1021/acs.jmedchem.5c03492 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Yong-Jin Wu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Oncology Discovery Chemistry Bristol Myers Squibb Research and Early Development, 250 Water Street, Cambridge, Massachusetts 02141, United States. Hauptthemen laut MEDLINE: Drug Design, Drug Discovery. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 359 Literaturangaben.
Abstract (Originalsprache)
Since its introduction in 1951, bioisosterism has become a cornerstone strategy in drug design and development, enabling chemists to rationally modify molecular structures to optimize biological and physicochemical properties. In this perspective, we examine 57 FDA-approved drugs and 18 advanced drug candidates wherein bioisosteric replacements were successfully employed to address a range of developability challenges encountered during lead optimization. These strategic substitutions have led to significant improvements in potency, selectivity, solubility, and metabolic stability, while simultaneously mitigating issues related to lipophilicity, plasma protein binding, and the formation of reactive metabolites. Together, these examples highlight the enduring impact of bioisosterism as a versatile tool for fine-tuning drug candidates and overcoming the multifaceted challenges of modern medicinal chemistry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Oncology Discovery Chemistry Bristol Myers Squibb Research and Early Development, 250 Water Street, Cambridge, Massachusetts 02141, United States.
ORCID-Profile: Yong-Jin Wu, Joanne J Bronson
Zitieren
APA
Wu, Y. J., Chmiel, A. F., & Bronson, J. J. (2026). Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.5c03492
Vancouver
Wu YJ, Chmiel AF, Bronson JJ. Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.5c03492
BibTeX
@article{Wu2026,
author = {Wu, Yong-Jin and Chmiel, Alyah F and Bronson, Joanne J},
title = {Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates},
journal = {Journal of Medicinal Chemistry},
year = {2026},
doi = {10.1021/acs.jmedchem.5c03492}
}
EUVIMED